Literature DB >> 34076737

Diversity and biopotential of Bacillus velezensis strains A6 and P42 against rice blast and bacterial blight of pomegranate.

Siddulakshmi Prasanna1, M K Prasannakumar2, H B Mahesh1, Gopal Venkatesh Babu3, P Kirnaymayee4, M E Puneeth1, Karthik S Narayan3, D Pramesh5.   

Abstract

Bacillus velezensis is widely known for its inherent biosynthetic potential to produce a wide range of bio-macromolecules and secondary metabolites, including polyketides (PKs) and siderophores, as well as ribosomally and non-ribosomally synthesized peptides. In the present study, we aimed to investigate the bio-macromolecules, such as proteins and peptides of Bacillus velezensis strains, namely A6 and P42 by whole-cell sequencing and highlighted the potential application in controlling phytopathogens. The bioactive compounds, specifically secondary metabolites, were characterized by whole-cell protein profiling, Thin-Layer Chromatography, Infra-Red Spectroscopy, Nuclear Magnetic Resonance, Gas Chromatograph and Electro Spray Liquid Chromatography. Gas Chromatography analysis revealed that the A6 and P42 strains exert different functional groups of compounds, such as aromatic ring, aliphatic, alkene, ketone, amine groups and carboxylic acid. Whole-cell protein profiling of A6 and P42 strains of B. velezensis by nano-ESI LC-MS/MS revealed the presence of 945 and 5303 proteins, respectively. The in vitro evaluation of crude extracts (10%) of A6 and P42 significantly inhibited the rice pathogen, Magnaporthe oryzae (MG01), whereas the cell-free culture filtrate (75%) of strain P42 showed 58.97% inhibition. Similarly, in vitro evaluation of crude extract (10%) of P42 strain inhibited bacterial blight of pomegranate pathogen, Xanthomonas axonopodis pv. punicae, which eventually resulted in a higher inhibition zone of 3 cm, whereas the cell-free extract (75%) of the same strain significantly suppressed the growth of the pathogen with an inhibition zone of 1.48 cm. From the results obtained, the crude secondary metabolites and cell-free filtrates (containing bio-macromolecules) of the strains A6 and P42 of B. velezensis can be employed for controlling the bacterial and fungal pathogens of crop plants.

Entities:  

Keywords:  Bacillus velezensis; Biocontrol; Magnaporthe oryzae; Secondary metabolites; Whole-cell protein profiling; Xanthomonas axonopodis pv. punicae

Year:  2021        PMID: 34076737     DOI: 10.1007/s00203-021-02400-9

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  10 in total

1.  Development of specific and quantitative methods for the quality control of the polysaccharides from sea-tangle and sargassum.

Authors:  Hua-Li Long; Jing-Xian Zhang; Ji-Ling Guo; Guo-Qi Sui; Jin-Jun Hou; Wen-Zhi Yang; Su-Mei Han; Wan-Ying Wu; De-An Guo
Journal:  Chin J Nat Med       Date:  2016-12

2.  The Gram Stain and Differential Staining.

Authors:  M L Kaplan; L Kaplan
Journal:  J Bacteriol       Date:  1933-03       Impact factor: 3.490

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Comprehensive peptidomic and glycomic evaluation reveals that sweet whey permeate from colostrum is a source of milk protein-derived peptides and oligosaccharides.

Authors:  David C Dallas; Valerie Weinborn; Juliana M L N de Moura Bell; Meng Wang; Evan A Parker; Andres Guerrero; Kasper A Hettinga; Carlito B Lebrilla; J Bruce German; Daniela Barile
Journal:  Food Res Int       Date:  2014-09-01       Impact factor: 6.475

5.  Exploring the Potentiality of Novel Rhizospheric Bacterial Strains against the Rice Blast Fungus Magnaporthe oryzae.

Authors:  Narayanappa Amruta; M K Prasanna Kumar; M E Puneeth; Gowdiperu Sarika; Hemanth Kumar Kandikattu; K Vishwanath; Sonnappa Narayanaswamy
Journal:  Plant Pathol J       Date:  2018-04-01       Impact factor: 1.795

Review 6.  Overview of the Antimicrobial Compounds Produced by Members of the Bacillus subtilis Group.

Authors:  Simon Caulier; Catherine Nannan; Annika Gillis; Florent Licciardi; Claude Bragard; Jacques Mahillon
Journal:  Front Microbiol       Date:  2019-02-26       Impact factor: 5.640

7.  Complex disease interventions from a network model for type 2 diabetes.

Authors:  Deniz Rende; Nihat Baysal; Betul Kirdar
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

8.  A cell-free translocation system using extracts of cultured insect cells to yield functional membrane proteins.

Authors:  Toru Ezure; Kei Nanatani; Yoko Sato; Satomi Suzuki; Keishi Aizawa; Satoshi Souma; Masaaki Ito; Takahiro Hohsaka; Gunnar von Heijine; Toshihiko Utsumi; Keietsu Abe; Eiji Ando; Nobuyuki Uozumi
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

9.  Antifungical Activity of Autochthonous Bacillus subtilis Isolated from Prosopis juliflora against Phytopathogenic Fungi.

Authors:  Ali Abdelmoteleb; Rosalba Troncoso-Rojas; Tania Gonzalez-Soto; Daniel González-Mendoza
Journal:  Mycobiology       Date:  2017-12-31       Impact factor: 1.858

10.  Antimicrobial Properties and Mechanism of Action of Some Plant Extracts Against Food Pathogens and Spoilage Microorganisms.

Authors:  Faraja D Gonelimali; Jiheng Lin; Wenhua Miao; Jinghu Xuan; Fedrick Charles; Meiling Chen; Shaimaa R Hatab
Journal:  Front Microbiol       Date:  2018-07-24       Impact factor: 5.640

  10 in total
  2 in total

1.  In silico prediction of putative antimicrobial targets in Xanthomonas citri pv. punicae using genome subtraction approach.

Authors:  K Dineshkumar; Ginny Antony
Journal:  Arch Microbiol       Date:  2022-07-15       Impact factor: 2.667

2.  Multi-Omics Techniques for Analysis Antifungal Mechanisms of Lipopeptides Produced by Bacillus velezensis GS-1 against Magnaporthe oryzae In Vitro.

Authors:  Yanhua Zhang; Meixi Zhao; Wei Chen; Huilin Yu; Wantong Jia; Hongyu Pan; Xianghui Zhang
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.